Prior high‐risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP‐certified laboratory

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|123|7|428-434

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.123, Iss.7, 2015-07, pp. : 428-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

History of high‐risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: Experience from the largest women's hospital in China

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 7, 2015-07 ,pp. : 421-427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Negative computer‐imaged ThinPrep Pap test and positive hybrid capture2 HPV co‐testing results: A quality assurance review

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 9, 2015-09 ,pp. : 763-769

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sensitivity of high‐risk HPVHybrid Capture II (hrHPV HC2) test using SurePathTM specimens in the prediction of cervical high‐grade squamous lesions

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 5, 2015-05 ,pp. : 381-387

John Wiley & Sons Inc

Access to resources Recommend Favorite

Study points to value of HPV screening for cervical cancer: Test may be viable alternative to Pap test

By  

CANCER, Vol. 120, Iss. 23, 2014-12 ,pp. : 3589-3590

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-risk human papillomavirus associated with incident cervical intraepithelial neoplasia developing in mothers in the Finnish Family HPV Study cohort

By Rintala Marjut A. M.   Louvanto Karolina   Rantanen Virpi   Grénman Seija E.   Syrjänen Kari J.   Syrjänen Stina M.  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 2, 2012-02 ,pp. : 115-125

Informa Healthcare

Access to resources Recommend Favorite